Efficacy and Safety of a Once-Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older

समान संसाधन

• Potential mediators of the mortality reduction with zoledronic acid after hip fracture
  द्वारा: Colón‐Emeric, Cathleen S, और अन्य
  प्रकाशित: (2009)
• Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture,
  द्वारा: Eriksen, Erik Fink, और अन्य
  प्रकाशित: (2009)
• Treatment of postmenopausal osteoporosis, patient perspectives – focus on once yearly zoledronic acid
  द्वारा: Carmona, Raj, और अन्य
  प्रकाशित: (2009)
• Time-to-onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis
  द्वारा: Boonen, Steven, और अन्य
  प्रकाशित: (2012)
• The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
  द्वारा: İlker Çorapçı, और अन्य
  प्रकाशित: (2004-03-01)